14395-52-9

Upstream product

• 3996-30-3 2-[(3-methylphenyl)thio]acetic acid 
• 1011460-45-9 S-4-bromo-3-methylphenyl dimethylcarbamothioate 
• 90483-65-1 (4-bromo-3-methyl-phenylsulfanyl)-acetic acid 
• 6933-10-4 amino-5-bromo-2-toluene 

Downstream Products

• 83365-24-6 bis-(4-bromo-3-methyl-phenyl)-disulfide 
• 90483-65-1 (4-bromo-3-methyl-phenylsulfanyl)-acetic acid 
• 78526-34-8 4'-(4-Bromo-3-methyl-phenylsulfanyl)-2,6-dimethyl-4'H-[1,1']bipyridinyl-4-one 
• 63179-14-6 2-(3-Methyl-4-brom-phenylthio)hexansaeure 
• 101084-83-7 4-Brom-3-methyl-phenylsulfenylchlorid 
• 90532-02-8 1-bromo-2-methyl-4-methylsulfanylbenzene 
• 78526-52-0 4-(4-Bromo-3-methyl-phenylsulfanyl)-pyridine 
• 135631-85-5 (3-methyl-4-bromophenyl)-3-methylbut-2-enyl-sulfide 
• 60877-18-1 [(2-Bromo-5-tolyl)thio]methanesulfonic acid, sodium salt 
• 89431-60-7 6-[4-(4-bromo-3-methyl-phenylmercapto)-butoxy]-4,4-dimethyl-4H-3,1-benzoxazin-2-one 

Relevant academic research and scientific papers

PHTHALAZINE, AZA- AND DIAZA-PHTHALAZINE COMPOUNDS AND METHODS OF USE

The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I wherein A1, A2/su

Cephalosporin displacement reaction

The present invention is directed to a process for the displacement of the acetoxy group of a cephalosporanic acid by a sulfur nucleophile, in an organic solvent and under essentially anhydrous conditions.